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A B S T R A C T
The aim of the present study was to assess whether EPC (endothelial progenitor cell)
number/function might be an explanatory factor for the observed relationship between Type D
personality (a joint tendency towards negative affectivity and social inhibition) and poor
cardiovascular prognosis. We also assessed whether the effect of a single exercise bout on
EPC number/function was affected by Type D personality. A total of 35 sedentary men with CHF
(chronic heart failure; left ventricular ejection fraction  45%) underwent CPET (cardiopulmonary
exercise testing) and personality assessment with the 14-item Type D scale. CD34+/KDR
(kinase insert domain-containing receptor)+ cells were quantified by flow cytometry before and
immediately after CPET. Migration of early EPC towards VEGF (vascular endothelial growth factor)
and SDF-1α (stromal-cell-derived factor-1α) was investigated. Type D (n = 10) and non-Type D
(n = 25) patients were comparable with regards to demographics, disease severity and Framingham
risk factor score. Circulating EPC numbers were reduced by 54% in Type D compared with
non-Type D patients (0.084 +− 0.055 and 0.183 +− 0.029% of lymphocytes respectively; P = 0.006).
Exercise led to a 60% increase in EPC in Type D patients, whereas the EPC number remained
unchanged in the non-Type D group (P = 0.049). Baseline migratory capacity was related to
disease severity, but was not different between Type D and non-Type D patients. Exercise induced
a highly significant enhancement of migratory capacity in both groups. In conclusion, reduced
EPC numbers might explain the impaired cardiovascular outcome in Type D patients. The larger
increase in circulating EPCs observed in these patients suggests that acute exercise elicits a more
pronounced stimulus for endothelial repair.
Key words: cardiopulmonary exercise test, chronic heart failure, endothelial progenitor cell, endothelium, migration, Type D
personality.
Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II type 1 receptor blocker; BMI, body mass
index; BP, blood pressure; CAD, coronary artery disease; CHF, chronic heart failure; CPET, cardiopulmonary exercise test; DS14,
14-item Type D scale; EPC, endothelial progenitor cell; FMD, flow-mediated dilation; IMT, intima media thickness; KDR, kinase
insert domain-containing receptor; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; NT-proBNP,
N-terminal pro-brain natriuretic peptide; TNF-α, tumour necrosis factor-α; V̇co2, carbon dioxide production; V̇e, expired minute
ventilation; V̇o2, oxygen consumption; V̇o2peak, peak V̇o2.
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INTRODUCTION
Type D personality, a joint tendency toward negative
affectivity and social inhibition, is associated with poor
prognosis in cardiovascular patients [1]. The relationship
between emotional distress and cardiovascular disease has
been linked to an unhealthy lifestyle, but also to more
physiological processes, such as disturbed autonomic
control [2], impaired platelet function [3] and a pro-
inflammatory environment [4]. Recently, decreased
numbers of EPCs (endothelial progenitor cells) have been
suggested as another possible mediator of cardiovascular
disorders in depressed patients [5]. In line with this,
psychosocial risk factors are related to levels of circulating
progenitor cells, independent of classical cardiovascular
risk factors [6].
Accumulating evidence suggests that the quantity and
function of circulating EPCs play an important role in
preserving endothelial integrity. These cells are released
from the bone marrow in response to ischaemia or
endothelial injury with the aim of repairing damaged
regions either by producing angiogenic cytokines [7] or
by differentiating into endothelial cells [8]. Besides re-
endothelialization, EPCs play a role in post-ischaemic
neoangiogenesis [9]. The therapeutic use of EPCs and
bone marrow mononuclear cells after vascular injury
appears promising [10,11], but safety issues need to be
addressed further [12].
In patients at cardiovascular risk [13], in those with
CAD (coronary artery disease) [14] and in CHF (chronic
heart failure) patients [15], the number of circulating
EPCs is reduced. In addition to this quantitative deficit,
a subnormal function of EPCs correlates with impaired
endothelial function [16]. Diversity in terms of EPC
definition and quantification methods has complicated
cross-study comparisons [17], sometimes leading to
paradoxical findings, such as increased numbers of EPCs
in patients with higher cardiovascular risk [18].
Psychological distress promotes immune dysregula-
tion [19], which in turn might mediate bone-marrow sup-
pression or cause depletion of EPCs in the peripheral cir-
culation. We have demonstrated previously that Type D
personality in CHF patients is independently associated
with increased circulating levels of TNF-α (tumour nec-
rosis factor-α) and its soluble receptors [20], which have
been shown to predict poor outcome in CHF [21,22].
Physical training has proved to be of clear benefit
in cardiovascular patients. Besides the central haemody-
namic effect, exercise tolerance is improved by partially
restoring vascular reactivity. Shear-stress-induced up-
regulation of eNOS (endothelial NO synthase) and a
decrease in oxidative stress play a central regulatory
function. Moreover, recent studies have demonstrated
that regular physical exercise mobilizes EPCs in CAD
and CHF patients [23], which might explain the observed
benefit on endothelial function. An acute exercise bout in
sedentary patients, however, poses a threat to endothelial
integrity by inducing vascular oxidative stress and a
transient prothrombotic stimulus.
In the present study, we investigated the relationship
between Type D personality and EPC numbers and
their function in CHF patients before and after




A total of 35 consecutive sedentary male CHF patients
with an LVEF (left ventricular ejection fraction)  45 %,
followed at the outpatient heart failure clinic of the
Department of Cardiology, were recruited for the present
study. Patients were stable with regard to symptoms
and therapy for at least 1 month, and were on standard
medical treatment consisting of ACEIs (angiotensin-
converting enzyme inhibitors) or ARBs (angiotensin
II type 1 receptor blockers), β-blockers, diuretics and
spironolactone as indicated. Patients with active infection
or cancer and patients on anti-inflammatory drugs were
excluded.
The study complies with the Declaration of Helsinki,
was approved by the local ethics committee and written
informed consent was obtained from all patients.
Study design
Complete clinical assessment, including resting BP (blood
pressure) measurement and NYHA (New York Heart
Association) classification, was performed at the time
of enrolment. The total burden of cardiovascular risk
factors was calculated using the Framingham risk factor
score [24]. LVEF was determined using echocardiography
(Simpson’s rule). Fasting blood samples were collected
in order to measure complete blood cell count, and
creatinine, glucose and lipid levels. Subjects performed
a symptom-limited CPET on a graded bicycle ergometer.
Immediately before and 10 min after peak exercise,
venous blood samples were drawn from an antecubital
vein and collected in acid citrate dextrose tubes. Samples
were processed immediately or stored at 4 ◦C and
analysed within 4 h.
Clinical data and Type D personality
All 35 patients completed a DS14 (14-item Type D scale).
DS14 comprises a seven item subscale measuring nega-
tive affectivity and a seven item subscale measuring
social inhibition. A cut-off of  10 on both DS14 sub-
scales was used to classify patients as Type D personality
[25].
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CPET
To obtain an optimal duration of CPET between 8 and
10 min, two ramp protocols were used: patients started
either with 20 or 40 W, with an incremental load of
10 compared with 20 W every minute respectively. A
12-lead ECG and heart rate were recorded continuously,
whereas automatic cuff BP was measured every 2 min
and at peak exercise. Breath-by-breath gas exchange
measurements allowed online determination of V̇e
(expired minute ventilation), V̇o2 (oxygen consumption)
and V̇co2 (carbon dioxide production) every 15 s. V̇o2peak
(peak V̇o2) was determined as the highest attained V̇o2
during the final 30 s of exercise and was also expressed
as a percentage of the predicted value. Online analysis of
V̇e/V̇o2 and V̇e/V̇co2 curves permitted the researchers
to encourage patients to exercise up to exhaustion.
Assessment of endothelium-dependent
vasodilation and IMT (intima media
thickness)
Endothelium-dependent vasodilation was assessed in
supine position by ultrasound of the right brachial
artery (AU5 ultrasound system; Esaote Biomedica). End-
diastolic diameters were evaluated at rest and during
reactive hyperaemia after inflating and deflating a forearm
BP cuff (200 mmHg or at least 50 mmHg above peak
systolic BP for 4 min). Post-occlusion measurements
were taken every 30 s and over the following 240 s.
FMD (flow-mediated dilation) was determined as the
percentage change in diameter between baseline and
maximal post-occlusion values.
IMT was measured with high-resolution ultrasound at
the posterior wall of the common carotid artery using an
automated edge-tracking method.
Quantification of circulating CD34+/KDR
(kinase insert domain-containing
receptor)+ cells
CD34 and KDR, commonly used membrane markers to
define EPCs, were detected on cells by flow cytometry
[26]. In brief, 200 μl of peripheral whole blood was
pre-treated with an FcR (Fc-receptor)-blocking reagent
(Miltenyi) to prevent non-specific binding and were in-
cubated with a PE (phycoerythrin)-conjugated anti-KDR
antibody (R&D Systems) and a PeCy7-conjugated anti-
CD34 antibody (BD Biosciences). After red blood cell
lysis with ammonium chloride (Stem Cell Technologies),
a total of 106 events was recorded on a FACSCantoII
flow cytometer (BD Biosciences). Time was entered as
a parameter to facilitate the identification and removal
of event bursts and minor clogs. Before analysis,
the flow cytometer was thoroughly cleaned to remove
residual cells. Fluorochrome- and isotype-matched
controls, as well as unstained cell samples, were
measured and processed as negative controls to set the
appropriate regions. The numbers of CD34+/KDR+
cells were analysed in the lymphocyte region using
FACSDiVa software and are expressed as a percentage
of lymphocytes.
Migratory activity of early EPCs
PBMCs (peripheral blood mononuclear cells) were isol-
ated by density gradient centrifugation with Lymphosep
(MP Biomedicals) and were cultured on fibronectin-
coated 24-well dishes in EGM-2 MV (Clontechs)
supplemented with 20 % (v/v) fetal calf serum. On
day 7, cells were characterized as early EPCs by the
uptake of acetylated LDL [DiI (1,1′-dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate)-acLDL; Mo-
lecular Probes] and binding of FITC-conjugated lectin
UEA-1 (Ulex europaeus agglutinin-1; Sigma). Migratory
activity of EPCs towards VEGF (vascular endothelial
growth factor; 50 ng/ml; R&D Systems) and SDF-
1α (stromal-cell-derived factor-1 α; 100 ng/ml; R&D
Systems) was determined using 5 μm transwells (Corning
Costar). After 4 h, viable EPCs that had migrated to
the lower chamber were stained with Trypan Blue
and counted manually using a haemocytometer. EPCs
counted in the negative control transwell (no addition
of chemoattractants) were subtracted from this number.
Migrated EPCs were expressed as a percentage of the total
cell number added to the transwell (positive control).
Statistical analysis
Continuous data are expressed as means +− S.E.M.
Normality of data was assessed using a one-sample
Kolmogorov–Smirnov test. Independent-sample Student
t and χ 2 tests were used as appropriate for baseline meas-
urements. Pre- and post-exercise data were compared in
the two groups using paired sampled Student’s t tests
with Levene’s test for equality of variances. Calculating
the difference in mean EPC levels between Type D and
non-Type D patients, and dividing it by the S.D. of the
total group at baseline, estimated an effect size of
Type D personality. An effect size of 0.50 reflects a
moderate effect, whereas 0.80 is a large effect [27]. In
order to estimate the magnitude of the Type D effect on
EPC numbers, we compared its effect size with those
of older age and standard cardiovascular risk factors. A
median split was used to dichotomize EPC levels in order
to stratify patients into high- and low-risk groups res-
pectively. Multiple logistic regression (method = enter)
was used to determine the risk associated with Type D
personality after controlling for age, BMI (body mass
index) and LVEF.
All analyses were performed using SPSS 16.0 for
Windows. A two-tailed P value of <0.05 was considered
statistically significant.
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Table 1 Demographic and clinical characteristics as a function of Type D personality
Values are means +− S.E.M., or numbers (%).
Characteristic Non-Type D (n = 25) Type D (n = 10) P value
Age (years) 63.4+− 2.6 56.3+− 3.0 0.1
BMI (kg/m2) 27.0+− 0.7 25.5+− 1.6 0.4
Framingham risk factor score 4.5 +− 0.6 5.2 +− 1.0 0.5
Diabetes mellitus (n) 2 (8 %) 1 (10 %) 0.7
Creatinine clearance rate (ml/min) 62.7+− 6.7 69.4+− 6.4 0.6
NYHA class I/II/III (n) 5/11/9 0/8/2 0.1
Ischaemic aetiology (n) 19 (76 %) 6 (60 %) 0.3
LVEF (%) 27.6+− 1.9 26.5+− 2.1 0.7
NT-proBNP (pg/dl) 1074+− 199 850+− 497 0.6
IMT (μm) 650.3+− 23.0 621.2+− 40.0 0.5
FMD (%) 5.2 +− 0.3 6.2 +− 1 0.2
V̇O2peak (ml·kg−1 of body weight·min−1) 20.5+− 2.0 23.7+− 2.4 0.4
Percentage of predicted V̇O2peak 81.9+− 4.6 83.0+− 8.1 0.9
V̇ E/V̇ CO2 slope 28.8+− 1.3 25.5+− 2.0 0.2
Medication (n)
ACEIs 23 (92 %) 9 (90 %) 0.9
ARBs 2 (8 %) 1 (10 %) 0.7
β-Blockers 22 (88 %) 10 (100 %) 0.5
Diuretics 20 (80 %) 8 (80 %) 1.0
Spironolactone 11 (44 %) 3 (30 %) 0.5
Statins 19 (76 %) 5 (50 %) 0.3
RESULTS
Patient characteristics according to
Type D classification
According to DS14, ten out of the 35 CHF patients
enrolled were classified as Type D. Demographic charac-
teristics, NYHA classification, LVEF, FMD, IMT, disease
aetiology, cardiovascular risk factors and medication were
comparable in Type D and non-Type D patients (Table 1).
None of the patients received any other medication
with known effects on EPC number and function [i.e.
PPAR-γ (peroxisome-proliferator-activated receptor-γ )
agonists, calcium antagonists, organic nitrates or PDE-5
(phosphodiesterase-5) inhibitors].
Baseline number of circulating
CD34+/KDR+ cells and function of early
EPCs
As shown in Figure 1, circulating EPC numbers
were significantly reduced (P = 0.006) by 54 % in
Type D patients (0.084 +− 0.055 % of lymphocytes)
compared with non-Type D patients (0.183 +− 0.029 % of
lymphocytes).
Figure 2 shows the importance of Type D personality
as a determinant of EPC number. An effect size of 0.8
indicated that Type D personality had a large effect on
EPC numbers. In comparison, advanced age (> 65 years)
(effect size = 0.46) and unfavourable standard cardiovas-
Figure 1 Comparison of circulating EPC numbers in CHF
patients with Type D (n = 10) and non-Type D (n = 25)
personality
EPCs (CD34+/KDR+ cells) are expressed as a percentage of total lymphocytes.
cular risk profile (effect size = 0.17) had small effects
(Figure 2). Hence the effect of Type D personality was
larger than that of these well-known determinants of
EPC numbers. Apart from Type D personality, age, BMI
and LVEF were included in a multiple logistic regression
model in order to control for factors known to influence
EPC numbers [15,28,29]. This model retained Type D
personality as an independent predictor of low EPC
C© The Authors Journal compilation C© 2009 Biochemical Society
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Figure 2 Effect size of advanced age, unfavourable cardio-
vascular risk profile and Type D personality as determinants
of the number of circulating EPCs
An effect size of 0.50 reflects a moderate effect and 0.80 a large effect on the
number of circulating EPCs. FR, Framingham risk score  6 (unfavourable
cardiovascular risk profile); Age > 65 (years), advanced age.
levels [odds ratio, 8.2 (95 % confidence interval, 1.2–57.4);
P = 0.034].
The number of circulating EPCs was not related to
determinants of disease severity such as poor LVEF and
reduced V̇o2peak (all P > 0.05).
Migratory capacity correlated with the percentage of
the predicted V̇o2peak (r = 0.334, P = 0.053) and inversely
with NT-proBNP (N-terminal pro-brain natriuretic
peptide) levels (r = −0.409, P = 0.031). However, the
migratory activity of early EPCs was not different in
Type D compared with non-Type D patients (34.9 +− 3.4
and 37.1 +− 5.4 % respectively; P = 0.73).
Effect of exercise on EPC number and
function
Changes in the number of circulating EPCs and
migratory activity of early EPCs following CPET are
shown in Figure 3. A single exercise bout led to a 60 %
increase in EPCs in Type D patients, whereas the EPC
number remained unchanged in the non-Type D group
(P = 0.049; Figure 3A). Migratory capacity of early EPCs
improved significantly after exercise in both Type D
and non-Type D patients (Figure 3B). This increase was
comparable in the two groups (P = 0.97).
DISCUSSION
Depletion and altered function of EPCs have been
demonstrated in CHF, which is characterized by
endothelial dysfunction. In cardiac patients, advanced
age and an unfavorable cardiovascular risk profile [14]
are well-known determinants of reduced circulating EPC
numbers. The results of the present study are the first to
suggest that Type D personality may also be associated
with a significantly impaired release and or/survival of
circulating EPCs in CHF patients.
Figure 3 EPC numbers (A) and migratory capacity (B) at
baseline and after a single maximal exercise bout in CHF
patients with Type D (n = 10) and non-Type D (n = 25)
personality
(A) EPCs (CD34+/KDR+ cells) are expressed as a percentage of total lymphocytes.
The change in EPCs following exercise was significantly different in Type D
patients compared with non-Type D patients. (B) EPC migratory capacity is
increased following exercise in both Type D and non-Type D patients. P values
are given for differences between Type D and non-Type D patients. *P < 0.05
compared with baseline; NS, not significant compared with baseline.
The potential importance of Type D personality was
demonstrated by its large effect size compared with
that of standard clinical factors affecting EPC numbers.
Individuals with Type D personality tend to experience
ongoing situations in their lives as stressful, which,
in turn, may elicit negative emotional reactions and
physiological hyper-reactivity every time a potentially
‘threatening’ situation is encountered [30]. Previous
studies have demonstrated that Type D personality is
independently associated with increased concentrations
of the pro-inflammatory cytokine TNF-α and its soluble
receptors [20], increased levels of the stress hormone
cortisol [31] and a disrupted autonomic balance [32].
These physiological stress mechanisms may help to clarify
the link between Type D personality and reduced EPC
numbers in the present study.
Dome et al. [5] recently showed an imbalance
of pro- and anti-inflammatory cytokines in patients
with depression, which was associated with reduced
EPC numbers. In the study by Valgimigli et al. [15],
C© The Authors Journal compilation C© 2009 Biochemical Society
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lower numbers of circulating EPCs in severe CHF were
linked to increased serum concentrations of TNF-α.
In vitro experiments have demonstrated that TNF-α
causes growth suppression of bone marrow CD34+
haemopoietic stem cells [33] and induces apoptosis of
peripheral circulating EPCs [34]. In line with this, it is
conceivable that the increased TNF-α activity observed
in Type D personality [35] induces the suppression of
bone marrow haemopoietic stem cells, thereby limiting
the number of circulating progenitor cells.
Activation of the HPA (hypothalamic–pituitary–
adrenal) axis in Type D personality and a subsequent
increased production of cortisol and catecholamines
[32,36] could provide a second plausible mechanism. Both
endogenously produced, as well as synthetic, steroids
induce substantial losses of lymphoid precursor cells
in the bone marrow via apoptotic pathways [37,38].
Moreover, hydrocortisone hampers the differentiation
of human CD34+ cells towards lymphocytes in in vitro
experiments [39].
Thirdly, it is conceivable that the disrupted autonomic
balance in Type D personality [2] partially accounts for
the lower EPC counts. The bone marrow is supplied
by autonomic sympathetic efferent innervation [40],
which plays a role in the proliferation and release of
haemopoietic cells from the bone marrow [41].
The maintenance of an intact endothelial monolayer,
either by adjacent mature endothelial cells or by
EPCs, prevents the development of atherosclerosis. EPCs
also affect disease progression and determine prognosis
independently of known cardiovascular risk factors [14].
To a large extent, endothelium-dependent vasodilation
determines the functional capacity of patients. Measures
taken to ameliorate endothelial vasoreactivity, such
as physical training, partially restore endothelial
dysfunction [22], and EPCs have been suggested as key
regulators. An acute exercise bout, however, poses a threat
to endothelial integrity by inducing vascular oxidative
stress and a transient prothrombotic stimulus. It has been
shown in healthy subjects that circulating EPC numbers
increase following a maximal exercise bout [42], thereby
supporting the conjecture that the generation of ROS (re-
active oxygen species) may trigger EPC release. The find-
ings of the present study demonstrate that the exercise-
induced stimulus for endothelial restoration is larger in
Type D patients than in non-Type D patients. The more
pronounced release of EPCs might be considered a mech-
anism of defence in order to compensate for the observed
chronic deficit in circulating EPC numbers at rest.
Although the number of circulating EPCs was lower
in Type D patients, their migratory capacity was not.
However, recent evidence suggests that CD34+/DKR+
cells and so-called ‘early EPCs’, cultivated in vitro,
are in fact different EPC subpopulations, characterized
by other antigenic cell-surface markers and different
angiogenic properties [43].
The present findings should be interpreted with cau-
tion, as the number of patients investigated was limited.
Nevertheless, the effect size for Type D personality
was remarkably high in comparison with known
determinants of circulating EPC numbers. The absence of
a relationship between EPC numbers and disease severity
in this small group of patients might be explained by the
fact that the group was rather homogenous. In addition,
the main purpose of the present study was to try to
identify disease-modifying mechanisms that might help
to explain why Type D patients are prone to repeated
cardiovascular events and poor prognosis.
Several studies have shown that Type D personality
predicts poor prognosis in cardiac patients. The exact
biological pathways by which Type D personality
predisposes to cardiovascular disease still awaits further
clarification. The findings of the present study are the first
to suggest that Type D personality may contribute to the
pathophysiology of cardiovascular disease by mediating
the number of circulating EPCs. Future studies should be
designed to investigate possible underlying mechanisms
using both in vivo and in vitro experiments.
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